BioScience Health Innovations, Inc.
BHIC
$4.13
-$0.05-1.20%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 86.53% | 208.34% | 207.22% | 260.04% | 231.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.53% | 208.34% | 207.22% | 260.04% | 231.53% |
| Cost of Revenue | 189.10% | 356.72% | 417.72% | 565.10% | 445.04% |
| Gross Profit | 43.65% | 147.59% | 149.32% | 190.27% | 184.88% |
| SG&A Expenses | 97.26% | 106.37% | 81.74% | 75.44% | 51.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 131.24% | 182.69% | 156.09% | 161.09% | 106.81% |
| Operating Income | -89.02% | 726.44% | 2,194.56% | 1,372.69% | 342.19% |
| Income Before Tax | -89.02% | 726.44% | 2,194.56% | 1,372.69% | 342.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -102.57% | 638.05% | 2,194.56% | 1,372.69% | 342.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -102.57% | 638.05% | 2,194.56% | 1,372.69% | 342.19% |
| EBIT | -89.02% | 726.44% | 2,194.56% | 1,372.69% | 342.19% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -102.60% | 257.32% | 1,371.43% | 859.21% | 199.14% |
| Normalized Basic EPS | -71.92% | 330.19% | 1,304.35% | 886.96% | 200.69% |
| EPS Diluted | -110.31% | 272.97% | 1,100.00% | 445.00% | 170.35% |
| Normalized Diluted EPS | -73.24% | 348.00% | 1,495.00% | 857.45% | 197.93% |
| Average Basic Shares Outstanding | -41.36% | 83.00% | 85.07% | 85.57% | 86.15% |
| Average Diluted Shares Outstanding | -42.26% | 80.19% | 85.01% | 88.41% | 89.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |